| Entry |
|
|---|
| Name |
HGF-overexpression to RAS-ERK signaling pathway
|
|---|
| Definition |
HGF* -> MET -> GRB2 -> SOS -> RAS -> RAF -> MEK -> ERK |
|---|
| Expanded |
3082v1 -> 4233 -> 2885 -> (6654,6655) -> (3265,3845,4893) -> (369,673,5894) -> (5604,5605) -> (5594,5595) |
|---|
| Class |
|
|---|
| Type |
Variant
|
|---|
| Pathway |
|
|---|
| Disease |
| H00048 | Hepatocellular carcinoma |
|
|---|
| Gene |
| 3082 | HGF; hepatocyte growth factor |
| 4233 | MET; MET proto-oncogene, receptor tyrosine kinase |
| 2885 | GRB2; growth factor receptor bound protein 2 |
| 6654 | SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 |
| 6655 | SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 |
| 3265 | HRAS; HRas proto-oncogene, GTPase |
| 3845 | KRAS; KRAS proto-oncogene, GTPase |
| 4893 | NRAS; NRAS proto-oncogene, GTPase |
| 369 | ARAF; A-Raf proto-oncogene, serine/threonine kinase |
| 673 | BRAF; B-Raf proto-oncogene, serine/threonine kinase |
| 5894 | RAF1; Raf-1 proto-oncogene, serine/threonine kinase |
| 5604 | MAP2K1; mitogen-activated protein kinase kinase 1 |
| 5605 | MAP2K2; mitogen-activated protein kinase kinase 2 |
| 5594 | MAPK1; mitogen-activated protein kinase 1 |
| 5595 | MAPK3; mitogen-activated protein kinase 3 |
|
|---|
| Variant |
3082v1 (HGF*) HGF overexpression
|
|---|
| Reference |
|
|---|
| Authors |
Breuhahn K, Longerich T, Schirmacher P |
|---|
| Title |
Dysregulation of growth factor signaling in human hepatocellular carcinoma. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Harding JJ, Abou-Alfa GK |
|---|
| Title |
Systemic therapy for hepatocellular carcinoma. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Lee D, Sung ES, Ahn JH, An S, Huh J, You WK |
|---|
| Title |
Development of antibody-based c-Met inhibitors for targeted cancer therapy. |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
